OnkoZentrum Zürich AG
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| HER2-directed Biosimilar in Breast Cancer: Real World ePRO (NCT05234021) | OnkoZentrum Zürich AG | 2021-12-14 |
| Efficacy of the "Consilium" Smartphone App for Detecting Symptoms and Treatment Side Effects in Cancer Patients (NCT03578731) | OnkoZentrum Zürich AG | 2018-03-05 |
Track OnkoZentrum Zürich AG automatically
Every clearance here is in the API, with alerts when new ones post.